Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0YXJPS
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
Veltuzumab-CL2E-SN-38
|
|||||
| Synonyms |
Vmab-CL2E-SN-38
Click to Show/Hide
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
6
|
|||||
| Antibody Name |
Veltuzumab
|
Antibody Info | ||||
| Antigen Name |
B-lymphocyte antigen CD20 (MS4A1)
|
Antigen Info | ||||
| Payload Name |
Active metabolite of irinotecan SN38
|
Payload Info | ||||
| Therapeutic Target |
DNA topoisomerase 1 (TOP1)
|
Target Info | ||||
| Linker Name |
CL2E
|
Linker Info | ||||
| Conjugate Type |
Random conjugation through reduced inter-chain cysteines.
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.